Follow the Carasent AB (publ) stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Healthcare & Pharma sector, Carasent AB (publ) has logged 14 reports. Market capitalisation: €1.7bn. The latest transaction was filed on 28 August 2026 (Purchase). Among the most active insiders: Johan Kallblad. The full history is openly available.
14
Insider Decl.
n/a
Thresholds
€299,669
12 ops.
Buy Volume
€145,402
2 ops.
Sell Volume
32Σ signal
Buys €299,669€145,402 Sells
Fundamental score
Ranked 13,085 of 29,062 companies
54.6
score / 100
Value
37
Quality
72
FCF yld-0.0%
Earn yld2.0%
EV/EBITDA18.2x
ROE5.2%
Gross mgn84%
Net mgn10%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
396 shares@ €2.00990.0005% mcap100.0% of flowAktieISINISIN SE0023261599FI:A003M446-1
14 of 14 declarations
About Carasent AB (publ)
Carasent AB (publ) is a publicly traded company on the Stockholm Stock Exchange, specializing in the health and pharmaceutical sector. It focuses on developing digital solutions to enhance patient care.